Ensuring predictability for COVID-19 clinical trials and proposal for clinical trials records retention: Notice to stakeholders
Description
The purpose of this notice is to advise stakeholders that Health Canada is proposing to: maintain the flexibilities and regulatory oversight provided by the Interim order respecting clinical trials for medical devices and drugs relating to COVID-19 until at least the fall of 2021, and bring forward regulatory amendments that would allow the flexibilities under the Interim Order to continue after the fall of 2021
Resources
| Name |
Format |
Description |
Link |
|
21 |
|
https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/conducting-clinical-trial/predictability-proposal-records-retention-notice.html |
|
21 |
|
https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/liste-essais-cliniques-autorise/previsibilite-proposition-conservation-registres-avis.html |